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ABSTRACT
Objective: Andrographolide was found to show moderate antimalarial activity against chloroquine-resistant strain of Plasmodium falciparum (PF). It 
thus becomes an interesting lead for new antimalarial drugs. This study describes a molecular docking of andrographolide and its derivative into the 
best PF geranylgeranyl pyrophosphate synthase (PFGGPPS) model.
Methods: A comparative modeling of PFGGPPS based on a crystal structure of Plasmodium vivax GGPPS was optimized and conducted. This model 
was considered suitable for molecular docking. Partition coefficient of andrographolide was determined to assist its derivative design based on 
hydrophobicity property. Synthesis of the antimalarial drug was scaled up to 5 mm and identified by13 C- and 1H-nuclear magnetic resonance (NMR) 
spectroscopy.
Results: The optimal comparative modeling of PFGGPPS was conducted on chain B (3PH7 chain B). The calculated coefficient partition of 
andrographolide’s derivative was higher (+1.89), compared to that of andrographolide of +1.62. The NMR data of second and third synthesis 
experiments were consistent at the 5-mmol scale.
Conclusions: On the molecular docking of andrographolide into the model, an antimalarial andrographolide derivative design that is more 
hydrophobic than andrographolide was proposed since the stronger hydrophobicity property of drug, the better of its activity of the drug. Synthesis 
of this derivative with a simple and green procedure was found to be reproducible.
Keywords: Plasmodium falciparum, Geranylgeranyl pyrophosphate synthase, Andrographolide, Comparative modeling, Molecular docking, Drug 
design and synthesis.
INTRODUCTION
Plasmodium falciparum (PF), a microorganism that belongs to the 
phylum Apicomplexa [1], is the most common cause of malaria in 
Indonesia [2]. The first-line treatment for uncomplicated PF malaria in 
the country is the artesunate-amodiaquine combination [2]. However, 
a failure rate of more than 10%, associated with drug resistance, was 
reported for this treatment in Indonesia for the period 2000-2007 [2]. 
This report presents the basis for a new antimalarial drug development 
in Indonesia. Geranylgeranyl pyrophosphate synthase (GGPPS) is a key 
enzyme in PF isoprenoid biosynthesis [3]. It catalyzes the synthesis of 
GGPP,3 as well as farnesyl pyrophosphate [3]. In the presence of Mg2+ 
cofactors [4]. It is recommended as an antimalarial drug target due 
to its amenability to high-throughput screening, druggability, and 
essentiality [5].
Andrographolide (Fig. 1) is the major secondary metabolite in an 
Indonesian herb, Sambiloto (Andrographis paniculata) [6]. It was found 
to have a moderate antimalarial activity against a chloroquine-resistant 
strain of PF [7], making it an interesting lead for new antimalarial drugs. 
Since it is biosynthesized from and similar to GGPP [8], it is reasonable 
to hypothesize that andrographolide exerts its antimalarial activity by 
inhibition of GGPPS. To establish this hypothesis by molecular docking, 
a crystal structure of PFGGPPS is needed, but this is not yet available.
Meanwhile, high-resolution GGPP-binding crystal structures of 
Plasmodium vivax GGPPS (PVGGPPS) are available (Protein Data 
Bank [PDB] 3CC9 [9] and 3PH7 [4]), based on a sequence available at 
UniProt [10] (A5K4U6 [11]). A basic local alignment search tool search 
on UniProt for this sequence gave a PFGGPPS sequence (Q86GK8 [12]) 
that was evidenced from transcript level. A >70% similarity between 
the two sequences was revealed in our preliminary sequence alignment 
by ClustalX 2.1 [13]. Therefore, it is feasible to make a comparative 
modeling of PFGGPPS using one the PVGGPPS crystal structures as the 
template.
In this paper, we report the aforementioned comparative modeling. 
Then, we describe a molecular docking of andrographolide into the 
best PFGGPPS model. Based on the results of this molecular docking, 
we propose an antimalarial andrographolide derivative design (Fig. 1), 
and we report our attempt to synthesize it.
METHODS
Comparative modeling of PFGGPPS
The comparative modeling was conducted by Modeller 9v16 interfaced 
by EasyModeller 4.0 [16]. A sequence of PFGGPPS downloaded 
from UniProt [10] as a FASTA file (Q86GK8 [12]) was employed 
as the query. A 2.5 Å-resolution GGPP-binding crystal structure of 
PVGGPPS downloaded from the Research Collaboratory for Structural 
Bioinformatics (RCSB). PDB [17] as a PDB file (PDB 3PH7) [14] 
was selected as the template. During the comparative modeling, 
heteroatoms were not included, and loops were not refined. Instead, 
the model with the lowest discrete optimized protein energy (DOPE) 
score was optimized by default parameters.
Preparation of PFGGPPS for molecular docking
The optimized model of PFGGPPS from the comparative modeling was 
prepared for molecular docking by OEDocking 3.0.1 [18]. Detection 
of its active site was carried out using a molecular method, which 
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was guided by Imprint Pocket [19]. The largest cavity indicated by 
Imprint Pocket was selected as the active site. Detection sensitivity was 
adjusted manually to ensure that all active site residues were covered. 
The molecular docking grid box was defined as 26.33×43.00×30.33 
Å3 = 34,347 Å3. Site shape potential was balanced (extended toward 
solvent and protein), and outer contour was set to 1,747 Å3. No 
constraint was applied.
Preparation of andrographolide and its derivative for molecular 
docking
A crystal structure of andrographolide (1) in CIF format [20] was 
used as a starting conformation of andrographolide. The format was 
converted into PDB by PyMOL 1.3 [21], and then this was converted 
into OpenEye native format (oeb) by VIDA 4.2.1 [22]. The structure 
of the andrographolide’s derivative (2) was built on this crystal 
structure by VIDA 4.2.1 [22]. Before molecular docking, every ligand 
was fixed to pKa = 7.0 and their tautomers assigned by QUACPAC 
1.6.3.1 [23,24]. Then, the derivative was filtered for drug-likenesses 
and its conformations generated by OMEGA 2.5.1.4 [25] using default 
parameters.
Molecular docking of andrographolide and its derivative
Molecular docking of the prepared ligands was conducted by OEDocking 
3.0.1 [18] in vacuo using default parameters. Every best docking pose 
was then subjected to optimization by SZYBKI 1.8.0.2 [26], considering 
a minimum distance of 2 Å between PFGGPPS active site residues and 
the ligand. In this optimization, protein-ligand interaction energies 
were calculated using Merck molecular force field (MMFF) van der 
Waals potential, in which MMFF Coulomb was digitized on the grid.
Calculation of partition coefficient of andrographolide and its 
derivative
A calculation of partition coefficient (log P) of andrographolide was 
conducted by ACD/Labs 12.01 [15] to assist the design of 2.
Synthesis of andrographolide derivative
Andrographolide (≥98%) was purchased from Xi’an App Chem-
Bio(Tech) Co., Ltd., P.R. China, and would expire on May 24, 2015. It 
appears as a white powder that dissolves in chloroform, ethyl acetate, 
and methanol [27,28], and it decomposes at 70°C [29].
To modify 1 into 2, andrographolide (1 mmol) was dissolved in 
methanol and reacted with anhydrous sodium carbonate (1 mmol) at 
50°C for 2 hrs, a procedure adapted from Pandeti et al. [30] The reaction 
was monitored by thin-layer chromatography every hour. The desired 
product was purified by solvent-solvent extraction (chloroform-
water 1:1), which was followed by column chromatography (eluent: 
100% ethyl acetate) and identified by 13C- and 1H-nuclear magnetic 
resonance (NMR) spectroscopy. The same experiment was repeated to 
assess reproducibility. Following a good confirmation, the procedure 
was scaled up to 5 mmol. Only at this point was the reaction yield 
calculated.
RESULTS AND DISCUSSION
Comparative modeling of PFGGPPS
Before the comparative EasyModeller, Modeler, aligned sequences 
of the template and query. For chains A to D of the template, the 
alignment scores were 265257.6250, 273733.8750, 252205.1562, 
and 260121.5312, respectively. Since chain B of the template gained 
the highest score for the alignment, and no gap presented at predicted 
secondary structures of the query (Fig. 2), the comparative modeling 
was conducted on chain B.
The comparative modeling produced seven models with the following 
DOPE scores: −45876.36719, −45724.93750, −45170.59375, 
−45537.06250, −45908.73047, −45727.52344, and −45883.46484. 
Model 5 received the lowest DOPE score, so it was optimized. After 
optimization of this model, a Ramachandran plot revealed only a few 
residues outside the allowed regions (Fig. 3). One of these residues was 
part of the PFGGPPS active site, according to Imprint Pocket (Fig. 2). 
Therefore, this PFGGPPS model was considered suitable for molecular 
docking. A comparison between the PVGGPPS crystal structure and 
PFGGPPS model is depicted in Fig. 4.
Molecular docking of andrographolide and its derivative
The active site of PVGGPPS consists of a hydrophobic anchor (L118, Q119, 
A120, F122, V156, Y160, T188, and I192; numbering differs 20 amino acids more 
than sequence numbering) and a catalytic pocket containing the first 
aspartate-rich motif (FARM; 126DDIMD130) and second aspartate-rich 
motif (SARM; 287DDYID291) [4]. GGPP positions itself in the PVGGPPS 
Fig. 1: Andrographolide (1) [14] and its proposed derivative (2) 
(drawn by ACD/Labs 12.01) [15]
Fig. 2: Sequence alignment of the template (3PH7 chain B) and 
query (Q86GK8). Gaps in the alignment are indicated by red dash; 
predicted alpha helix structures for the query are constructed 
by underlined amino acids; no beta structure was predicted 
for the query by modeller; the active Plasmodium falciparum 
geranylgeranyl pyrophosphate synthase site, according to Imprint 
Pocket, is constructed by italicized amino acids; outliers in the 
Ramachandran plot are colored red in Fig. 3
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active site such that its hydrophobic part is held by the anchor while 
its pyrophosphate group interacts with the catalytic pocket [4]. In our 
docking pose of andrographolide, the hydroxyl groups at C-3 and C-19 
pointed toward the SARM of PFGGPPS, while its lactone group pointed 
toward the hydrophobic anchor (Fig. 5).
The overall energy of the interaction between andrographolide and 
PFGGPPS was −70.81114 kcal/mol (comprising electrostatic and 
van der Waals interactions of −58.43179 and −12.37936 kcal/mol, 
respectively). Stronger electrostatic interactions should be expected 
in the presence of Mg2+ cofactors and water molecules. This finding 
suggests that the andrographolide hydroxyl groups at C-3 and C-19 
were essential for hydrophilic interactions, while its lactone group 
could be modified to become more hydrophobic.
To examine this suggestion, we proposed a design for an andrographolide 
derivative (2) which was more hydrophobic than andrographolide at its 
lactone group. On docking into PFGGPPS, this derivative gave a highly similar 
position and orientation (Fig. 5). Its affinity toward PFGGPPS was lost 
slightly, as indicated by a decrease in the overall ligand-protein interaction 
energy (down by about an 8th, to −61.90828 kcal/mol). However, the van der 
Waals contribution in the interaction energy increased by approximately 
one-third, to −16.40830 kcal/mol, suggesting that the pre-modified lactone 
group at two bound more tightly to the hydrophobic anchor of PFGGPPS.
Since an antimalarial drug should penetrate the membrane of PF 
cell and work within the cell, its activity is part determined by 
its hydrophobicity, which is reflected by its partition coefficient 
(log P): The higher its log P (until +5.00, according to Lipinski’s Rule 
of Five) [31], the better it penetrates the membrane and the higher 
is its activity. The calculated log P of 2 is +1.89, compared to that of 
andrographolide of +1.62. Therefore, 2 is expected to penetrate the 
membrane better. This pharmacokinetic profile could compensate the 
previous pharmacodynamic one.
Synthesis of the andrographolide derivative
The above procedure was selected because it is considered simple and 
sufficiently green, so it is suitable for drug synthesis. Below is the result 
of the 13C- and 1H-NMR for the first experiment:
Fig. 3: Ramachandran plot of the optimized Plasmodium 
falciparum geranylgeranyl pyrophosphate synthase model 5
Fig. 4: Comparison between the Plasmodium vivax geranylgeranyl 
pyrophosphate synthase crystal structure (green) and our 
Plasmodium falciparum geranylgeranyl pyrophosphate synthase 
model (red) (image generated by PyMOL 1.3) [21]
Fig. 5: Docking pose of andrographolide (green sticks) and 
derivative (pink sticks) in Plasmodium falciparum geranylgeranyl 
pyrophosphate synthase. The first aspartate-rich motif is on the 
right, and the second aspartate-rich motif is at the bottom; on 
the left is the hydrophobic anchor of PFGGPPS active site (image 
generated by PyMOL 1.3) [21]
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13C NMR (101 MHz, CDCl3) δ 198.53, 169.88, 167.27, 148.10, 146.89, 
146.69, 142.65, 142.58, 124.22, 124.15, 123.44, 108.59, 108.43, 108.15, 
102.34, 80.19, 77.46, 77.34, 77.14, 76.82, 64.15, 56.72, 56.00, 55.70, 
55.10, 55.05, 52.16, 42.64, 42.02, 38.84, 38.76, 37.78, 37.68, 36.94, 
36.88, 32.77, 32.73, 28.04, 25.63, 24.38, 23.68, 22.81, 15.22, 15.18.
1H NMR (400 MHz, CDCl3) δ 9.68, 9.59, 9.56, 7.50, 7.24, 7.14, 6.97, 6.89, 
6.82, 6.78, 6.75, 6.62, 6.42, 6.09, 6.07, 6.02, 5.97, 5.42, 5.31, 5.04, 4.91, 
4.77, 4.76, 4.71, 4.54, 4.45, 4.38, 4.33, 4.30, 4.12, 4.09, 3.66, 3.45, 3.40, 
3.38, 3.24, 3.22, 2.95, 2.91, 2.74, 2.64, 2.60, 2.47, 2.35, 2.32, 2.22, 2.12, 
1.91, 1.89, 1.73, 1.66, 1.49, 1.45, 1.41, 1.35, 1.32, 1.26, 1.22, 1.16, 0.81, 
0.74, 0.60, 0.44, -0.00.
These NMR data were consistent for the second and third experiments, 
suggesting a high reproducibility for the procedure. At the 5-mmol 
scale, the reaction yield was 60.94%.
The 13C-NMR peak near 200 ppm suggests that the andrographolide 
hydroxyl group at C-19 may have been oxidized by sodium carbonate 
into an aldehyde. This by-product would be anticipated, since the 
andrographolide hydroxyl group at C-19 is also vulnerable and 
selective protection had not been applied. We have to bear in mind 
also that protection requires more steps and may not be sufficiently 
green for drug synthesis [32]. The presence of this by-product should 
be investigated further by analytical and preparative high-performance 
liquid chromatography and liquid chromatography–mass spectroscopy.
CONCLUSION
A comparative modeling of PFGGPPS based on a PVGGPPS crystal 
structure (3PH7 chain B) was conducted, and the model was 
considered suitable for molecular docking. On molecular docking 
of andrographolide into the model, the design of an antimalarial 
andrographolide derivative, which is more hydrophobic than 
andrographolide, was proposed. Synthesis of this with a simple and 
green procedure was found to be reproducible at a 5-mmol scale.
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